XDNY:F:F-Xtrackers MSCI Japan ESG Screened UCITS ETF 1D (EUR)

ETF | Others |

Last Closing

USD 15.584

Change

-0.11 (-0.68)%

Market Cap

USD 60.46B

Volume

1.18K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-17 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

+0.05 (+0.17%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.61 (+1.21%)

USD 112.01B
SXR8:F iShares Core S&P 500 UCITS ETF..

+0.26 (+0.05%)

USD 94.11B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+0.14 (+0.25%)

USD 93.50B
SXRZ:F iShares VII PLC - iShares Nikk..

-0.55 (-0.23%)

USD 56.46B
VUAA:F Vanguard S&P 500 UCITS Acc

-0.03 (-0.03%)

USD 51.63B
VUSA:F Vanguard Funds Public Limited ..

N/A

USD 51.63B
XJSE:F Xtrackers II - Japan Governmen..

+0.01 (+0.13%)

USD 39.38B
0ZC:F Zscaler Inc

-1.14 (-0.65%)

USD 37.92B
BSND:F Danone SA

+0.10 (+0.85%)

USD 33.83B

ETFs Containing XDNY:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 12.83% 74% C 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.83% 71% C- 60% D-
Trailing 12 Months  
Capital Gain 14.66% 64% D 66% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 14.66% 61% D- 58% F
Trailing 5 Years  
Capital Gain 30.94% 54% F 60% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 30.94% 54% F 47% F
Average Annual (5 Year Horizon)  
Capital Gain 4.43% 58% F 60% D-
Dividend Return 4.43% 56% F 53% F
Total Return N/A 68% D+ 95% A
Risk Return Profile  
Volatility (Standard Deviation) 11.67% 57% F 82% B
Risk Adjusted Return 37.95% 56% F 63% D
Market Capitalization 60.46B 99% N/A 97% N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:

There is nothing we particularly dislike